Primary sinonasal lymphoma: A multi‐institutional experience of clinical presentation, treatment, and outcomes

Background Sinonasal lymphoma (SL) is a heterogeneous, underrecognized neoplastic disorder with limited outcomes data. We sought to better define outcomes by subtype and treatment at 2 referral centers over the past 2 decades. Methods Demographics, clinicopathologic data, and treatment outcomes for...

Full description

Saved in:
Bibliographic Details
Published in:International forum of allergy & rhinology 2023-08, Vol.13 (8), p.1492-1502
Main Authors: Eide, Jacob G., Kshirsagar, Rijul S., Birkenbeuel, Jack L., Abello, Eric H., Hobday, Sara, Herzberg, Sabrina, Wang, Beverly Y., Palmer, James N., Adappa, Nithin D., Kuan, Edward C.
Format: Article
Language:English
Subjects:
B cell
Chemotherapy
Disease control
Head & neck cancer
Immunotherapy
Lymphoma
Multivariate analysis
NK/T cell
Nose
outcomes
Patients
Radiation
Radiation therapy
sinus tumors
skull base
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Sinonasal lymphoma (SL) is a heterogeneous, underrecognized neoplastic disorder with limited outcomes data. We sought to better define outcomes by subtype and treatment at 2 referral centers over the past 2 decades. Methods Demographics, clinicopathologic data, and treatment outcomes for patients treated for SL were queried from January 1, 2000 to December 31, 2021 at 2 tertiary academic medical centers. Results Eighty‐four patients were included, with an average age at diagnosis of 63.4 ± 15 years. There were 34 females (40.5%). The majority of patients had an Eastern Cooperative Oncology Group (ECOG) score of
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.23102